IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

NCT05268172 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pleural Effusion, Malignant

Interventions

DRUG: IFN-γ and CIK cells, Tcm cells or CAR T cells

Sponsor

Affiliated Hospital of Jiangnan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]